Healthvista India Ltd - IPO

Healthvista India Ltd IPO Details

Initial public offering of up to [*] equity shares of face value of Re. 1 each (Equity Shares) of Healthvista India Limited (the Company or the Issuer) for cash at a price of Rs. [*] per equity share including a share premium of Rs. [*] per equity share (the Offer Price) aggregating up to Rs. [*] crores (the Offer). The offer comprises of a fresh issue of up to [*] equity shares by the company aggregating up to Rs. 200.00 crores (the Fresh Issue) and an offer for sale of up to 56,252,654 equity shares (the Offered Shares) aggregating up to Rs. [*] crores (the Offer for Sale), comprising of up to 12,070,214 equity shares aggregating up to Rs. [*] crores by Accel Growth iii Holdings (<Mauritius) Limited, up to 8,504,709 equity shares aggregating up to Rs. [*] crores by Accel India iii (Mauritius) Limited, up to 4,278,680 equity shares aggregating up to Rs. [*] crores by Ventureast Life Fund iii llc, 4,445,735 equity shares aggregating up to Rs. [*] crores by Memg CDC Ventures, up to 4,256,924 equity shares aggregating up to Rs. [*] crores by Qualcomm Asia Pacific Pte. ltd, up to 4,229,951 equity shares aggregating up to Rs. [*] crores by Accel India v (Mauritius) Limited, up to 3,984,752 equity shares aggregating up to Rs. [*] crores by Sabre Partners Trust, up to 3,974,614 equity shares aggregating up to Rs. [*] crores by Sama Family Trust, up to 3,889,144 equity shares aggregating up to Rs. [*] crores by International Finance Corporation, up to 2,626,963 equity shares aggregating up to Rs. [*] crores by Ventureast Trustee Company Private Limited, up to 1,741,701 equity shares aggregating up to Rs. [*] crores by Aneja Schmidt & Co. llc, up to 1,741,701 equity shares aggregating up to Rs. [*] crores by Cyperales vl, llc, and up to 507,566 equity shares aggregating up to Rs. [*] crores by Medi Assist Healthcare Services Limited (the Selling Shareholders ) (the Offer for Sale, and together with the fresh issue, is referred to as the Offer). The offer will constitute [*]% of the post-offer paid-up equity share capital of the company. The company may, in consultation with the selling shareholders and the book running lead managers (brlms), consider issuing such number of equity shares on a private placement basis for cash consideration aggregating up to Rs. 40.00 crores, with the roc (the pre-ipo placement). The price of the equity shares allotted pursuant to the pre-ipo placement shall be determined by the company and the selling shareholders in consultation with the brlms. if the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with rule 19(2)(b) of the securities contracts (regulation) rules, 1957, as amended (the scrr). The face value of the equity share is Re. 1 each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot size will be decided by the company.

Objective of issue

Funding the working capital requirements of Medybiz Pharma Pvt Ltd(the company material Subsidiary). Re-peyment/prepayment of certain indebtedness availed by the company. Purchase of medical equipment. Marketing and brand building activities. Inorganic growth initiatives and general corporare purposes.

Healthvista India Ltd Contact Details

Healthvista India Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083

Phone - 91-22-49186000

Fax - 91-22-49186060

Email - investors@porteamedical.com

Website - www.portea.com